New Information Technology Findings from Kyoto Pharmaceutical University Discussed [The Use of Topical Antibiotics Based On the National Database of Health Insurance Claims and Specific Health Checkups of Japan (Ndb) Open Data In 2017]: Information Technology

2022 MAY 17 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Data detailed on Information Technology have been presented. According to news reporting originating from Kyoto, Japan, by NewsRx correspondents, research stated, “The national action plan on antimicrobial resistance (AMR) in Japan emphasizes the importance of understanding antimicrobial use (AMU). Some studies have been conducted on oral and parenteral AMU in Japan.”

Financial support for this research came from Ministry of Health, Labour and Welfare, Japan.

Our news editors obtained a quote from the research from Kyoto Pharmaceutical University, “However, there are few studies on the use of topical antimicrobials, such as in dermatology and ophthalmology. Therefore, the purpose of this study was to investigate the use of topical AMU in Japan. Data on AMU in dermatology and ophthalmology were obtained from the 2017 National Database of Health Insurance Claims and Specific Health Checkups of Japan Open Data. The number of dermatological products used was 58,396,530 in 2017. The proportions of betamethasone/gentamicin and gentamicin used were 50.5% and 16.7%, respectively, whereas that of the ingredient quantity in gentamicin was 7.8%. It has been suggested that topical AMU should be evaluated based on the number of products being used. The number of ophthalmological products used was 24,655,653 in 2017, and the proportion of quinolones used was 95.9%. The high prescription rate of quinolones may cause an increase in quinolone resistance in the ophthalmologic field.”

According to the news editors, the research concluded: “Topical AMU, which is a potential ‘blind spot’ in the measures against AMR, needs to be continuously monitored, together with systemic AMU.”

This research has been peer-reviewed.

For more information on this research see: The Use of Topical Antibiotics Based On the National Database of Health Insurance Claims and Specific Health Checkups of Japan (Ndb) Open Data In 2017. Japanese Journal of Infectious Diseases, 2022;75(2):177-182. Japanese Journal of Infectious Diseases can be contacted at: Natl Inst Infectious Diseases, Jpn J Infect Dis Ed Off Natl Inst Infectious Diseases Toyama 1-23-1, Shinjuku-Ku, Tokyo, 162-8640, Japan.

The news editors report that additional information may be obtained by contacting Yuichi Muraki, Kyoto Pharmaceutical University, Dept Clin Pharmacoepidemiol, Kyoto, Japan. Additional authors for this research include Tomoko Nakanishi, Ryo Inose, Yoshiki Kusama, Masahiro Ishikane, Norio Ohmagari, Toshiki Kajihara, Koji Yahara, Motoyuki Sugai and Hiroki Ohge.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.7883/yoken.JJID.2021.450. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)